Inflammation and Repair Research Domain
The MAHSC Inflammation & Repair Research Domain works closely with our Greater Manchester universities and research-intensive NHS Trusts. This spans basic, clinical and translational innovation at the interface of infection, immunity, inflammation and repair. Basic Science research is carried out across Greater Manchester, including Manchester Collaborative Centre for Inflammation and Repair, Versus Arthritis Centres in Genetics and Genomics, and Epidemiology and in the Manchester Fungal Infection Group.
We also bring together experts in academia and healthcare to work on innovative new treatments and ways of delivering care – and take advantage of some of the excellent facilities in Greater Manchester, a region internationally recognised as a centre of expertise for research into inflammation and repair.
We are leaders in precision medicine, an approach that stratifies patients with a particular disease according to how they respond to therapies. The aim is to get the right treatment to the right person at the right time. We have significantly increased our precision medicine infrastructure through the NIHR Manchester Biomedical Research Centre.
In our NIHR Manchester Biomedical Research Centre, we are driving forward pioneering research into new tests and treatments in musculoskeletal disease, hearing health, respiratory disease, dermatology and four cancer themes (prevention, radiotherapy and precision medicine), utilising our expertise in biomarkers, informatics and the rapid translation of research findings.
Our domain works across these areas:
Selected activity ongoing within the Inflammation and Repair Research Domain:
- Activation of inflammation and Coagulation after Trauma II (ACIT-II)
- OPTASIA pilot of Optimal software
- The TAPER Feasibility Study
- Postgraduate Studentship awards, providing funding to Masters’ and PhD-level students to complete research projects.
- Small funding awards – further information on active calls can be found here.